Results 151 to 160 of about 123,936 (306)

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

On Consumers' Attitudes and Willingness to Pay for Improved Drinking Water Quality and Infrastructure

Replaced with revised version of paper 07/23/09.willingness to pay, risk perceptions, water infrastructure, simultaneous equation model, Environmental Economics and Policy,
Mykerezi, Elton, Bosch, Darrell J., Tanellari, Eftila   +2 more
core  

Do price-tags influence consumers' willingness to pay ? On external validity of using auctions for measuring value [PDF]

The paper considers the external validity of the growing set of literature that uses laboratory auctions to reveal consumers' willingness to pay for consumer goods, when the concerned goods are sold in retailing shops through posted prices procedures ...
Muller, L., Ruffieux, B.
core  

Revertant Mosaicism Obscures Long‐Awaited Molecular Confirmation of Diamond‐Blackfan Anemia

American Journal of Medical Genetics Part A, EarlyView.
Nicholas A. Borja, Mustafa Tekin
wiley   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Gendered dimensions of sustainable land management: Evidences from farm size and training effects on willingness to pay in Ghana's Volta Region. [PDF]

PLoS One
Fiagborlo JD, Nyatuame M, Ntoko SA.
europepmc   +1 more source

Italian consumers’ willingness to pay for renewable energy sources

EU Directive 2009/72/CE imposes to the European Countries environmental and energy targets. The Italian goal is to attain a 17% share in electricity production from renewable energy sources (RES) by 2020.
Polinori, Paolo, Bigerna, Simona
core  

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Willingness to pay for a quality-adjusted life year in Iran: a systematic review. [PDF]

Cost Eff Resour Alloc
Hashempour R, AbolhasanBeigi Gallehzan N, Akhavan Rezayat S, Raei B, Esmaeili R, Emamgholipour Sefiddashti S.   +5 more
europepmc   +1 more source

Willingness to Pay for Drinking Water and Sanitation Availability in Indonesia [PDF]

When sustainability of access and quality, is the primary concern, water and saniatioan should be considered as economic goods. Therefore, we need more accurate information on the amount of people’s willingness to pay.
Bilang Nauli Harahap, Djoni Hartono
core